Abstract:Circulating cell-free DNA (cfDNA) released by damaged cells causes inflammation and has been associated with the progression of sepsis. One proposed strategy to treat sepsis is to scavenge this inflammatory circulating cfDNA. Here, we develop a cfDNA-scavenging nanoparticle (NP) that consists of cationic polyethylenimine (PEI) of different molecular weight grafted to zeolitic imidazolate framework-8 (PEI-g-ZIF) in a simple one-pot process. PEI-g-ZIF NPs fabricated using PEI 1800 and PEI 25k but not PEI 600 suppressed cfDNA-induced TLR activation and subsequent nuclear factor kappa B pathway activity. PEI 1800-g-ZIF NPs showed greater inhibition of cfDNA-associated inflammation and multiple organ injury than naked PEI 1800 (lacking ZIF), and had greater therapeutic efficacy in treating sepsis. These results indicate that PEI-g-ZIF NPs acts as a "nanotrap" that improves upon naked PEI in scavenging circulating cfDNA, reducing inflammation, and reversing the progression of sepsis, thus providing a novel strategy for sepsis treatment.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.nanolett.0c04759?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.nanolett.0c04759</a>.Materials and methods; (Figure S1) characterization of materials; (Figure S2) BET surface area result of NPs; (Figure S3) TGA analysis of NPs; (Figure S4) schematic of activation of HEK-Blue hTLR reporter cells by agonists; (Figure S5) activation of HEK-Blue hTLR9, hTLR3, and hTLR4 reporter cells by materals (no agonists added); (Figure S6) activation of (A) HEK-Blue hTLR9 and (B) hTLR4 cells after treatment of ZIF-8 with different weight ratio to agonists; (Figure S7) ROS level of cells from the peritoneal cavity of mice in different treatment groups; (Figure S8) H&E staining images of major organs of mice in different treatment groups; (Figure S9) blood biochemistry analysis of mice in different treatment groups; (Figure S10) H&E staining images of major organs of mice after injection with free PEI 1800 and PEI 1800-g-ZIF NPs for 5 days; and (Table S1) Zn content analysis of ZIF-8 and PEI-g-ZIF NPs (<a class="ext-link" href="/doi/suppl/10.1021/acs.nanolett.0c04759/suppl_file/nl0c04759_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Treatment of Severe Sepsis with Nanoparticulate Cell-Free DNA Scavengers

A Cationic Metal–Organic Framework to Scavenge Cell-Free DNA for Severe Sepsis Management

Modulation of Unregulated Inflammation‐Associated Coagulopathy in Sepsis Using Multifunctional Nanosheets

Nanoplatforms for Sepsis Management: Rapid Detection/Warning, Pathogen Elimination and Restoring Immune Homeostasis

Treating Acute Lung Injury Through Scavenging of Cell-Free DNA by Cationic Nanoparticles

Inhibiting DNA Methylation Improves Survival in Severe Sepsis by Regulating NF-κB Pathway.

Bioengineered Stem Cell Membrane Functionalized Nanoparticles Combine Anti-Inflammatory and Antimicrobial Properties for Sepsis Treatment

A nanotrap improves survival in severe sepsis by attenuating hyperinflammation

Inflammation-targeting Polymeric Nanoparticles Deliver Sparfloxacin and Tacrolimus for Combating Acute Lung Sepsis.

Targeting multiple mediators of sepsis using multifunctional tannic acid-Zn2+-gentamicin nanoparticles

Multifunctional Endogenous Small Molecule-Derived Polymer Composite Nanoparticles for the Treatment of Acute Sepsis Therapy

Functionalized Core–Shell Nanogel Scavenger for Immune Modulation Therapy in Sepsis

Targeting multiple mediators of sepsis using multifunctional tannic acid-Zn<SUP>2+</SUP>-gentamicin nanoparticles

Cell-membrane-coated nanoparticles for the fight against pathogenic bacteria, toxins, and inflammatory cytokines associated with sepsis

Precise engineering of neutrophil membrane coated with polymeric nanoparticles concurrently absorbing of proinflammatory cytokines and endotoxins for management of sepsis

Macrophage-like nanoparticles concurrently absorbing endotoxins and proinflammatory cytokines for sepsis management

Self-assembled Carbon Monoxide Nanogenerators Managing Sepsis Through Scavenging Multiple Inflammatory Mediators

Sepsis Treatment Strategies Based on Nanomaterials

Decoy Nanozymes Enable Multitarget Blockade of Proinflammatory Cascades for the Treatment of Multi-Drug-Resistant Bacterial Sepsis

NAD(H)-loaded nanoparticles for efficient sepsis therapy via modulating immune and vascular homeostasis

Apoptotic Body Based Biomimetic Hybrid Nanovesicles to Attenuate Cytokine Storms for Sepsis Treatment